Skip to main content

Advertisement

SpringerLink
Log in

Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

An Erratum to this article was published on 11 October 2016

Abstract

Background

The objective of this study was to investigate whether the genetic polymorphism rs12665607 of ESR1, rs10995190 of ZNF365, rs3817198 of LSP1 and rs17001868 of SGSM3/MKL1 are associated with the development of breast cancer (BC) in the Chinese women.

Methods

The 4 SNPs were genotyped for 453 female BC patients and 750 controls. The differences of genotype and allele distributions between patients and controls were evaluated using the Chi-square test. The comparison of SGSM3 expression in the tumor and the adjacent normal breast tissues was carried out by the Student’s t test. One-way ANOVA test was used to analyze the relationship between genotypes of rs17001868 and the tissue expression of SGSM3.

Results

Patients were found to have significantly higher allele T of rs12665607 and allele C of rs17001868 than that of the controls (35.2 % vs. 29.6 %, p = 0.004 for rs12665607; 23.1 % vs. 19.1 %, p = 0.02 for rs17001868). The OR values were 1.29 for rs12665607 and 1.27 for rs17001868, respectively. The mean expression level of SGSM3 was significantly lower in BC tumors than in the adjacent normal tissues (0.0082 ± 0.0038 vs. 0.0134 ± 0.0078; p < 0.001). Patients with genotype CC were found to have a remarkably lower SGSM3 expression in the tumors than those with genotype AA (p = 0.007).

Conclusions

ESR1 gene and the SGSM3 gene are associated with the risk of BC in Chinese population. Besides, rs17001868 may be a putative functional variant that can affect the expression of SGSM3 in patients with BC. With the OR ranging from 1.27 to 1.29, variants of these 2 genes can only explain limited variance of BC. Further investigations into the functional role of the susceptible genes would be helpful to clarify the etiology of BC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011;53(5):372–84.

    PubMed  Google Scholar 

  2. Khanna R, Bhanegaonkar A, Colsher P, Madhavan SS, Halverson J. Breast cancer screening, incidence, and mortality in West Virginia. W Va Med J. 2009;105:Spec No: 24–32.

  3. Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19(Suppl 1):33–41.

    Article  PubMed  Google Scholar 

  4. Benson JR, Purushotham A. Trends in breast cancer incidence, survival, and mortality. Lancet. 2000;356(9229):591 (author reply 593).

    Article  CAS  PubMed  Google Scholar 

  5. Berkemeyer S, Lemke D, Hense HW. Incidence and mortality trends in German women with breast cancer using age, period and cohort 1999–2008. PLoS One. 2016;11(3):e0150723.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Brewster D, Everington D, Harkness E, Gould A, Warner J, Dewar JA, et al. Incidence of and mortality from breast cancer since introduction of screening. Scottish figures show higher incidence and similar mortality. BMJ. 1996;312(7031):639–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dite GS, Stone J, Chiarelli AM, Giles GG, English DR, Cawson JC, et al. Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index? Breast Cancer Res Treat. 2012;131(2):553–9.

    Article  PubMed  Google Scholar 

  8. Reeves GK, Pirie K, Green J, Bull D, Beral V. Million women study C: comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. Int J Cancer. 2012;131(4):930–7.

    Article  CAS  PubMed  Google Scholar 

  9. Yoshimoto N, Nishiyama T, Toyama T, Takahashi S, Shiraki N, Sugiura H, et al. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Cancer Sci. 2011;102(11):2065–72.

    Article  CAS  PubMed  Google Scholar 

  10. Fourati A, Louchez MM, Fournier J, Gamoudi A, Rahal K, El May MV, et al. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer. Bull Cancer. 2014;101(11):E36–40.

    PubMed  Google Scholar 

  11. Konecny M, Milly M, Zavodna K, Weismanova E, Gregorova J, Mlkva I, et al. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia. Breast Cancer Res Treat. 2011;126(1):119–30.

    Article  CAS  PubMed  Google Scholar 

  12. Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH. Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer. 2011;10(2):199–205.

    Article  PubMed  Google Scholar 

  13. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996;77(4):697–709.

    Article  CAS  PubMed  Google Scholar 

  15. Lee SA, Lee KM, Lee SJ, Yoo KY, Park SK, Noh DY, et al. Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk. Nutr Cancer. 2010;62(8):1087–94.

    Article  CAS  PubMed  Google Scholar 

  16. Jara L, Gonzalez-Hormazabal P, Cerceno K, Di Capua GA, Reyes JM, Blanco R, et al. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. Breast Cancer Res Treat. 2013;137(2):559–69.

    Article  CAS  PubMed  Google Scholar 

  17. Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L, et al. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population. Breast Cancer Res Treat. 2010;124(1):237–41.

    Article  CAS  PubMed  Google Scholar 

  18. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet. 2002;71(2):432–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wong MW, Nordfors C, Mossman D, Pecenpetelovska G, Avery-Kiejda KA, Talseth-Palmer B, et al. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat. 2011;127(3):853–9.

    Article  CAS  PubMed  Google Scholar 

  20. Cai Q, Zhang B, Sung H, Low SK, Kweon SS, Lu W, et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nat Genet. 2014;46(8):886–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet. 2012;44(3):312–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39(7):870–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(3):324–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Lindstrom S, Thompson DJ, Paterson AD, Li J, Gierach GL, Scott C, et al. Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun. 2014;5:5303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–4.

    Article  PubMed  Google Scholar 

  28. Barzan D, Veldwijk MR, Herskind C, Li Y, Zhang B, Sperk E, et al. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. Eur J Hum Genet EJHG. 2013;21(11):1286–92.

    Article  CAS  PubMed  Google Scholar 

  29. Hong Y, Chen XQ, Li JY, Liu C, Shen N, Zhu BB, et al. Current evidence on the association between rs3757318 of C6orf97 and breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev APJCP. 2014;15(19):8051–5.

    Article  PubMed  Google Scholar 

  30. Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75(12):2457–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chen W, Song H, Zhong R, Zhu B, Guo H, Lou J, et al. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis. Breast Cancer Res Treat. 2013;142(3):637–44.

    Article  CAS  PubMed  Google Scholar 

  32. Zhou L, He N, Feng T, Geng T, Jin T, Chen C. Association of five single nucleotide polymorphisms at 6q25.1 with breast cancer risk in northwestern China. Am J Cancer Res. 2015;5(8):2467–75.

    PubMed  PubMed Central  Google Scholar 

  33. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353–61 (361e351-352).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nourashrafeddin S, Aarabi M, Modarressi MH, Rahmati M, Nouri M. The evaluation of WBP2NL-Related genes expression in breast cancer. Pathol Oncol Res POR. 2015;21(2):293–300.

    Article  CAS  PubMed  Google Scholar 

  35. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:930–4.

    Article  Google Scholar 

Download references

Acknowledgments

We sincerely thank Dr. Liang Tao for his assistance in the proof-reading of our manuscript.

Author information

Authors and Affiliations

  1. Department of General Surgery, Jiangsu Province Geriatric Hospital, Jiangsu Road No. 65, Nanjing, 210008, China

    Tan Tan & Wenjun Chen Sun

  2. Department of General Surgery, The Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, 210008, China

    Kai Zhang

Authors
  1. Tan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenjun Chen Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wenjun Chen Sun.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s12282-016-0724-1.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, T., Zhang, K. & Sun, W.C. Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population. Breast Cancer 24, 369–374 (2017). https://doi.org/10.1007/s12282-016-0712-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-016-0712-5

Keywords

Search

Navigation